A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
NCT01568385
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastric Ulcer
Duodenal Ulcer
Interventions
DRUG:
TAK-438
Sponsor
Takeda